Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.
Impact of Integration
The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
CVS Health to Open 1,500 HealthHUB Locations By The End of 2021
CVS Health, today announced a significant expansion of HealthHUB locations at CVS Pharmacy stores across the country. Building on the success and customer response to its HealthHUB pilot in Houston, the company plans to open additional locations in Houston, Atlanta, Philadelphia, southern New Jersey and Tampa this year, and plans to have 1,500 HealthHUB locations operating by the end of 2021.Recent HealthHUB Pilot in HoustonFor the past six months, the company has been piloting three HealthHUB
Read More
EarlySign Unveils Commercial Availability of AI Diabetes Risk Predictors Algorithm
Medial EarlySign – an Israeli health AI company
has just announced the commercial availability of its first suite of machine
learning-based predictive diabetes risk solutions. Expanding the company’s
portfolio of clinical risk predictors, these new diabetes-focused AlgoMarkers
are designed to help healthcare systems identify and engage patients at high
risk for diabetes and downstream
Read More
Welkin Health Lands $17.5M for Patient Relationship Management Platform
Welkin Health, a digital health company based in San Francisco has raised $17.5M in Series B funding led by Altos Ventures. Existing investors, Thrive Capital, Red Swan Ventures, and Asset Management Ventures also contributed to the round, which brings Welkin’s total funding to $30 million to date. The company plans to use that latest round of funding to expand operations and its business reach.
Helping Care Teams Have Meaningful Relationships With Their Patients
Founded in 2013, Welkin’s
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Glooko, a provider of diabetes data management solutions, today announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.
Dr. Clements comes to Glooko from the University of Missouri-Kansas City School of Medicine, where he is Associate
Read More
Solera Health Raises $42M to Scale Integrated Benefit Network for Chronic Disease Prevention
Solera Health, a Phoenix, AZ-based technology-enabled integrated benefit network has raised $42 million in Series C funding led by HCSC Ventures. Current investors BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures also participated in the most recent funding round. The Series C round, Solera's largest to date, brings its total funding to $72 million.Integrated Benefit NetworkFounded in 2015, Solera Health serves as an integrated benefit network
Read More
Livongo for Diabetes Program Reduced Medical Spending by 22% for Members, Study Finds
The Livongo for Diabetes program delivered a 21.9 percent reduction in medical spending for Livongo members when compared to the matched non-Livongo population, according to study findings published in the latest edition of the Journal of Medical Economics. When taking the average price of the Livongo for Diabetes program into account, the study demonstrated that employers experienced a positive return on investment in one year.Financial Impact of Diabetes Management in the U.S.Diabetes is one
Read More
Podimetrics Raises $13.4M for FDA-Cleared Solution to Prevent Diabetic Foot Ulcers
Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcer (DFUs) has raised $13.4M in Series B funding round from investors Rock Health, Norwich Ventures, and Scientific Health Development.Impact of Diabetic Foot Ulcers for PatientsDiabetic foot ulcers are a major complication of diabetes and are one of the most devastating and costliest diabetes complications -they can lead to debilitating amputations that cost on average $100k. In
Read More
DispatchHealth Nabs $33M to Expand On-Demand Healthcare Model to High Acuity Patients
DispatchHealth (formerly known as True North Health Navigation), a Denver, CO-based provider of on-demand healthcare delivery to a patient’s home has raised $33 million in growth capital funding led by Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions. The funding also included participation from existing investors Alta Partners, Questa Capital and additional strategic investors.Founded in 2013 by two mobile health executives, DispatchHealth’s
Read More
